Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 073 in Secondary Hyperparathyroidism of Chronic Kidney Disease
NCT00042653Phase 3Completed
- Sponsor
- Amgen
- Start
- May 2002
- Primary completion
- Jul 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by Amgen. Started May 2002; status: completed.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00042653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00042653.